137 related articles for article (PubMed ID: 1302164)
21. What have the ACE-inhibitor trials in postmyocardial patients with left ventricular dysfunction taught us?
Reynolds G; Hall AS; Ball SG
Eur J Clin Pharmacol; 1996; 49 Suppl 1():S35-9. PubMed ID: 8834930
[TBL] [Abstract][Full Text] [Related]
22. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
23. Blocking the renin-angiotensin system: dual- versus mono-therapy.
Ravandi A; Teo KK
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
[TBL] [Abstract][Full Text] [Related]
24. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
[TBL] [Abstract][Full Text] [Related]
25. [Digoxin and angiotensin-converting enzyme inhibitors in the treatment of chronic congestive heart failure].
Thery C
Therapie; 1994; 49(3):211-8. PubMed ID: 7878586
[TBL] [Abstract][Full Text] [Related]
26. [Resistance to ACE inhibitors. Myth or reality?].
Aumont MC; Juliard JM
Arch Mal Coeur Vaiss; 2001 Sep; 94(9):1008-12. PubMed ID: 11603063
[TBL] [Abstract][Full Text] [Related]
27. [ACE-inhibitors in acute heart infarct].
Genoni M; Garzoli G; Pfister M; Siegrist P; Malacrida R; Maggioni A; Moccetti T
Praxis (Bern 1994); 1996 Apr; 85(17):548-53. PubMed ID: 8668893
[TBL] [Abstract][Full Text] [Related]
28. [Angiotensin-converting enzyme inhibitors and/or angiotensin II receptors antagonists in the treatment of arterial hypertension].
Silance PG
Rev Med Brux; 2003 Sep; 24(4):A253-6. PubMed ID: 14606289
[TBL] [Abstract][Full Text] [Related]
29. [Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
Modesti PA; Vanni S; Gensini GF
Ital Heart J Suppl; 2003 Aug; 4(8):623-34. PubMed ID: 14655458
[TBL] [Abstract][Full Text] [Related]
30. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
Sigurdsson A
Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
[TBL] [Abstract][Full Text] [Related]
31. [New aspects of ACE inhibitor treatment of heart failure].
Dietz R; Osterziel KJ
Z Kardiol; 1996; 85 Suppl 6():241-6. PubMed ID: 9064971
[TBL] [Abstract][Full Text] [Related]
32. Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials.
Young JB
Cardiovasc Drugs Ther; 1995 Feb; 9(1):89-102. PubMed ID: 7786840
[TBL] [Abstract][Full Text] [Related]
33. Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.
Goa KL; Balfour JA; Zuanetti G
Drugs; 1996 Oct; 52(4):564-88. PubMed ID: 8891468
[TBL] [Abstract][Full Text] [Related]
34. Who should be treated with angiotensin-converting enzyme inhibitors after myocardial infarction?
Ball SG; Hall AS
Am Heart J; 1996 Jul; 132(1 Pt 2 Su):244-50. PubMed ID: 8677863
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease?
Doggrell SA
Expert Opin Pharmacother; 2002 Nov; 3(11):1543-56. PubMed ID: 12437489
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin-converting enzyme inhibitors as cardioprotective agents.
Massie BM
Am J Cardiol; 1992 Dec; 70(21):10I-17I. PubMed ID: 1471600
[TBL] [Abstract][Full Text] [Related]
37. Cardioprotection with angiotensin-converting enzyme inhibitors: redefined for the 1990s.
Kloner RA; Przyklenk K
Clin Cardiol; 1993 Feb; 16(2):95-103. PubMed ID: 8435934
[TBL] [Abstract][Full Text] [Related]
38. Contribution of bradykinin to the cardioprotective action of angiotensin converting enzyme inhibition in hypertension and after myocardial infarction.
Ito K; Zhu YZ; Zhu YC; Gohlke P; Unger T
Jpn J Pharmacol; 1997 Dec; 75(4):311-8. PubMed ID: 9469636
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-converting enzyme inhibitors.
Brown NJ; Vaughan DE
Circulation; 1998 Apr; 97(14):1411-20. PubMed ID: 9577953
[TBL] [Abstract][Full Text] [Related]
40. Summary of randomized trials of angiotensin converting enzyme inhibitors.
Yusuf S; Lonn E; Bosch J; Gerstein H
Clin Exp Hypertens; 1999; 21(5-6):835-45. PubMed ID: 10423106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
